Home
>
National Drug Code (NDC)
>
ALTACE
ALTACE - 61570-111-01 - (ramipril)
Drug Information of ALTACE
| Product NDC: | 61570-111 |
| Proprietary Name: | ALTACE |
| Non Proprietary Name: | ramipril |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; ramipril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ALTACE
| Product NDC: | 61570-111 |
| Labeler Name: | Monarch Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019901 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19910128 |
Package Information of ALTACE
| Package NDC: | 61570-111-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (61570-111-01) |
NDC Information of ALTACE
| NDC Code | 61570-111-01 |
| Proprietary Name | ALTACE |
| Package Description | 100 CAPSULE in 1 BOTTLE (61570-111-01) |
| Product NDC | 61570-111 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ramipril |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19910128 |
| Marketing Category Name | NDA |
| Labeler Name | Monarch Pharmaceuticals, Inc. |
| Substance Name | RAMIPRIL |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
